Literature DB >> 8065859

Lupus nephritis in children--a review of 167 patients.

L Y Yang1, W P Chen, C Y Lin.   

Abstract

BACKGROUND: Relatively few studies have been made of children with lupus nephritis. The prognosis of children with lupus nephritis is ominous for those with diffuse proliferative glomerulonephritis and active interstitial inflammation. Up to now few studies have been made on this subject.
OBJECTIVES: To evaluate the clinical course, histopathology, and prognosis of lupus nephritis in children, to identify the risk factors for renal failure and mortality, and to share our experience in treating lupus nephritis in children.
METHODS: Retrospectively, 167 children under 18 years of age with lupus nephritis at Veterans General Hospital-Taipei, Taiwan from 1979 to 1991 were studied. All patients received renal biopsy and follow-up biopsies were performed in 36 children. The clinical and serologic parameters at the time of renal biopsy were recorded.
RESULTS: There were 55 (33%) patients with class II, 30 (18%) with class III, 69 (41.3%) with class IV, and 13 (7.8%) with class V nephritis based on initial biopsy. The mean follow-up time was 59 months. Follow-up biopsies were histologically stationary in 29 patients, progressive in five, and regressive in two. The results revealed that those with persistent hypertension, anemia, increased serum creatinine concentration, and decreased creatinine clearance rate at initial biopsy were more prone to develop renal failure. Low titer of CH50 hemolytic assay appeared to be a poor prognostic indicator. The overall renal and patient 5-year survival rates were 93.1% (135/145) and 91.08% (143/157), respectively. They were 87.7% (50/57) and 82% (55/67), respectively, of patients with class IV proliferative glomerulonephritis.
CONCLUSIONS: The prognosis of children with class IV nephritis in this study was better than that reported previously. All children surviving without renal failure were maintaining their normal lives with little organ dysfunction. The improved results may be due to earlier renal biopsy for precise histopathologic definition, better supportive care, and selective use of aggressive therapy, including methylprednisolone pulse therapy, intravenous cyclophosphamide, intravenous prostaglandin E1 therapy, high-dose intravenous gammaglobulin therapy, and cyclosporin A for those with high risk factors.

Entities:  

Mesh:

Year:  1994        PMID: 8065859

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  28 in total

Review 1.  The use of immunosuppressive and cytotoxic drugs in non-malignant disease.

Authors:  P A Brogan; M J Dillon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

2.  Lupus nephritis in Chinese children--a territory-wide cohort study in Hong Kong.

Authors:  Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Stella Chim; Kwok-Piu Lee; Reann Wai-Po Chu; Winnie Chan; Kwok-Wah Fong; Joannie Hui; Samantha Po-Siu Li; Pa-Shing Yeung; So-Fun Yuen; Assunta Chi-Hang Ho; Lettie Chuk-Kwan Leung; David Luk; Pak-Chiu Tong; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow; David Lau
Journal:  Pediatr Nephrol       Date:  2006-04-26       Impact factor: 3.714

Review 3.  Treatment of severe proliferative lupus nephritis: the current state.

Authors:  C C Mok; R W S Wong; K N Lai
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

4.  Full-house nephropathy in a patient with negative serology for lupus.

Authors:  Esra Baskin; Pinar Isik Agras; Nurcan Menekşe; Handan Ozdemir; Nurcan Cengiz
Journal:  Rheumatol Int       Date:  2006-09-14       Impact factor: 2.631

5.  Clinical presentation and outcomes of childhood-onset membranous lupus nephritis.

Authors:  Maria Pereira; Eyal Muscal; Karen Eldin; M John Hicks; Anna Carmela P Sagcal-Gironella; Marietta DeGuzman; Scott E Wenderfer
Journal:  Pediatr Nephrol       Date:  2017-07-17       Impact factor: 3.714

Review 6.  Treatment of young patients with lupus nephritis using calcineurin inhibitors.

Authors:  Hiroshi Tanaka; Kazushi Tsuruga; Tomomi Aizawa-Yashiro; Shojiro Watanabe; Tadaatsu Imaizumi
Journal:  World J Nephrol       Date:  2012-12-06

Review 7.  Prevalence and burden of pediatric-onset systemic lupus erythematosus.

Authors:  Sylvia Kamphuis; Earl D Silverman
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

8.  Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Koichi Suzuki; Tohru Nakahata; Etsuro Ito
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

9.  Childhood lupus nephritis: 12 years experience from North India.

Authors:  Surjit Singh; Ranjana Minz; Ritambhra Nada; Kusum Joshi
Journal:  Rheumatol Int       Date:  2006-05       Impact factor: 2.631

10.  Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.

Authors:  Abdurahman Saud Al Arfaj; Najma Khalil; Salman Al Saleh
Journal:  Rheumatol Int       Date:  2009-04-21       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.